Surgical treatment of non-small cell lung cancer in patients 70 years of age or older

被引:0
作者
Ciriaco, P [1 ]
Zannini, P [1 ]
Carretta, A [1 ]
Melloni, G [1 ]
Chiesa, G [1 ]
Canneto, B [1 ]
Puglisi, A [1 ]
机构
[1] Hosp San Raffaele, Inst Sci, Dept Cardio Thorac Surg, I-20132 Milan, Italy
关键词
elderly patients; non small cell lung cancer; postoperative complication;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Indications to surgical treatment of lung cancer in the elderly are still being discussed. The aim of this study was to evaluate postoperative complications and survival after surgery for non-small cell lung cancer (NSCLC) in patients 70 years of age or older. Methods. During a 4 year and 6 month period, 76 patients (67 men and 9 women) entered the study. Results. Postoperative complications occurred in 15 cases (19.7 %) and the 30-day operative mortality was 1.3%. The overall 54 month actuarial survival was 53%. Mortality at 12 months wasn't related to stage of disease, histology or lobectomy versus wedge resection but was higher in those patients who had had postoperative cardiopulmonary complications. Results of preoperative spirometry, blood gas and cardiac status were predictive of mortality at twelve months (p<0.05). Conclusions. Surgery for NSCLC in the elderly should not be denied on the basis of age alone. Postoperative outcome is mainly related to concomitant cardiopulmonary disease.
引用
收藏
页码:4 / 7
页数:4
相关论文
共 50 条
[41]   The Role of Sublobar Resection for the Surgical Treatment of Non-Small Cell Lung Cancer [J].
Behinaein, Parnia ;
Treffalls, John ;
Hutchings, Hollis ;
Okereke, Ikenna C. .
CURRENT ONCOLOGY, 2023, 30 (07) :7019-7030
[42]   Surgical treatment of stage I and II non-small cell lung cancer [J].
Klotz, Laura V. ;
Winter, Hauke .
ONKOLOGE, 2018, 24 (12) :1009-1014
[43]   Conditional Survival after Surgical Treatment of Non-Small Cell Lung Cancer [J].
Fukui, Takayuki ;
Okasaka, Toshiki ;
Kawaguchi, Koji ;
Fukumoto, Koichi ;
Nakamura, Shota ;
Yokoi, Kohei .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S438-S438
[44]   Non-small cell lung cancer. Palliative chemotherapy in stage IV non-small cell lung cancer and in patients with comorbidity [J].
M. Reck ;
K.M. Deppermann ;
U. Gatzemeier ;
N. Niederle .
Der Onkologe, 2006, 12 (8) :761-768
[45]   Stage I Non-small Cell Lung Cancer (NSCLC) in Patients Aged 75 Years and Older Does Age Determine Survival After Radical Treatment? [J].
Palma, David A. ;
Tyldesley, Scott ;
Sheehan, Finbarr ;
Mohamed, Islam G. ;
Smith, Sally ;
Wai, Elaine ;
Murray, Nevin ;
Senan, Suresh .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) :818-824
[46]   Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older [J].
Furuta, M ;
Hayakawa, K ;
Katano, S ;
Saito, Y ;
Nakayama, Y ;
Takahashi, T ;
Imai, R ;
Ebara, T ;
Mitsuhashi, N ;
Niibe, H .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (02) :95-98
[48]   Checkpoint inhibitors in older patients with advanced non-small cell lung cancer [J].
Reale, Maria Lucia ;
Romano, Gianpiero Diego ;
Paolelli, Loretta ;
Leo, Silvana .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
[49]   The use of immunotherapy in older patients with advanced non-small cell lung cancer [J].
Tagliamento, Marco ;
Frelaut, Maxime ;
Baldini, Capucine ;
Naigeon, Marie ;
Nencioni, Alessio ;
Chaput, Nathalie ;
Besse, Benjamin .
CANCER TREATMENT REVIEWS, 2022, 106
[50]   Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancer [J].
O'Leary, Connor ;
McSorley, Lynda ;
Hennessy, Bryan ;
Grogan, Liam ;
Breathnach, Oscar ;
Morris, Patrick .
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) :2185-2194